| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 152626-75-0 | 6-Methoxy-5-nitro-1H-indazole | C8H7N3O3 |
| 152626-77-2 | 4-Bromo-5-methoxy-2-methylaniline | C8H10BrNO |
| 152626-78-3 | 5-Bromo-6-methoxy-1H-indazole | C8H7BrN2O |
| 152628-00-7 | Methyl 4-methyl-2-propyl-1H-benzimidazole-6-carboxylate | C13H16N2O2 |
| 152628-01-8 | Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate | C13H16N2O5 |
| 152628-02-9 | 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole | C19H20N4 |
| 152628-03-0 | 4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid | C12H14N2O2 |
| 152636-45-8 | 2-Propenoic acid 4'-[bis(4-methylphenyl)amino][1,1'-biphenyl]-4-yl ester | C29H25NO2 |
| 152645-33-5 | 5-Methyl-2-nitrophenyl isocyanate | C8H6N2O3 |
| 152646-95-2 | Ono-4007 sodium salt | C50H78NNaO12S |
| 152647-29-5 | L-Isoleucyl-L-leucyl-L-arginylglycyl-L-seryl-L-valyl-L-alanyl-L-histidyl-L-lysine | C43H77N15O11 |
| 152657-84-6 | Nalfurafine | C28H32N2O5 |
| 152658-17-8 | Nalfurafine hydrochloride | C28H32N2O5.HCl |
| 152670-41-2 | N,N'-Di(1-naphthyl)-4,4'-benzidine | C32H24N2 |
| 152684-26-9 | 5-Bromo-3-methoxy-2-nitro-pyridine | C6H5BrN2O3 |
| 152684-30-5 | 5-Bromo-2-methoxy-3-nitropyridine | C6H5BrN2O3 |
| 152685-91-1 | Cimiside B | C40H64O13 |
| 152697-45-5 | Uridine 5'-diphosphoglucose | C15H24N2O17P2 |
| 152708-24-2 | Valsartan azide impurity | C14H11N7 |
| 152743-19-6 | Lysionotin | C18H16O7 |
| 152751-57-0 | Sevelamer hydrochloride | (C3H7N)m.(C3H5ClO)n.(HCl)x |
| 152763-53-6 | Thulium tris[bis(trimethylsilyl)amide] | 3(C6H18NSi2).Tm |
| 152772-65-1 | L-Gluconic acid calcium salt (2:1) | 2(C6H11O7).Ca |
| 152775-45-6 | 3,5-Dimethyl-4-methoxybenzonitrile | C10H11NO |
| 152784-32-2 | 4-(2,4-Dihydroxyphenyl)-5-[(4-hydroxyphenyl)methyl]-2(5H)-furanone | C17H14O5 |
| 152787-59-2 | Proteinase inhibitor, TCPI | |
| 152803-24-2 | 5-Hydroxynicotinonitrile | C6H4N2O |
| 152807-26-6 | 3-(4'-Fluorobenzoyl)indole | C15H10FNO |
| 152811-62-6 | Piboserod | C22H31N3O2 |
| 152812-42-5 | Methyl 2-chloroindole-3-carboxylate | C10H8ClNO2 |
| 152828-23-4 | N-[5-(1,1-Dimethylethyl)-1H-pyrazol-3-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide | C14H17N5O3 |
| 152828-25-6 | 2-(4-Aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | C12H11N5 |
| 152840-65-8 | 2,6-Dichloro-5-fluoro-3-pyridinamine | C5H3Cl2FN2 |
| 152840-71-6 | 1-Bromo-3-chloro-2,4,5-trifluorobenzene | C6HBrClF3 |
| 152854-19-8 | 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-pyridine (2R,3R)-2,3-dihydroxybutanedioate (1:1) | C14H23N3OS .C4H6O6 |
| 152894-10-5 | N,N-Bis(pentafluoroethanesulphonyl)imide | C4HF10NO4S2 |
| 152897-19-3 | 1,1,3,3-Tetramethoxycyclobutane | C8H16O4 |
| 152914-68-6 | Undecyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | C19H37NO6 |
| 152918-18-8 | N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide | C18H19IN6O4 |
| 152918-47-3 | 1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide | C14H16ClN5O4 |
| 152922-71-9 | 1-(Hydroxymethyl)cyclopropaneacetonitrile | C6H9NO |
| 152922-73-1 | Methyl 1-(Mercaptomethyl)cyclopropaneacetate | C7H12O2S |
| 152923-56-3 | Daclizumab | |
| 152923-57-4 | Lutropin | |
| 152932-65-5 | O-6-Deoxy-alpha-L-galactopyranosyl-(1$rarr$3)-O-[3-O-sulfo-beta-D-galactopyranosyl-(1$rarr$4)]-2-(acetylamino)-2-deoxy-beta-D-glucopyranose | C20H35NO18S |
| 152937-04-7 | 2-Bromo-6-fluorobenzothiazole | C7H3BrFNS |
| 152940-76-6 | 1-[(4-Bromophenyl)sulfonyl]-1H-imidazole | C9H7BrN2O2S |
| 152943-33-4 | Bupropion USP Related Compound C | C9H9ClO2 |
| 152946-68-4 | Nolatrexed dihydrochloride | C14H12N4OS.2(HCl) |
| 152957-34-1 | 2-Nitrophenyl 2-(acetylamino)-2-deoxy-beta-D-galactopyranoside | C14H18N2O8 |